What are the opening hours?

Monday 10am - 5:30pm Tuesday 10am - 5:30pm Wednesday 10am - 5:30pm Thursday 10am - 5:30pm Saturday 10am - 5:30pm

Dr. Michael Cørnwall, 2785 E Desert Inn Road, Suite 280, Las Vegas, NV (2026)

03/01/2026

The Psychology of Small Change: How Three New Actions a Day Can Improve Mental Health

Michael Cornwall, PsyD, PhD

Abstract

Mental health improvement is often framed as requiring large, sustained changes, yet behavioral science suggests that small, consistent novelty can significantly improve emotional regulation and psychological resilience. This essay explores the idea that performing three new actions daily for two weeks can enhance mental health management. Drawing from research on neuroplasticity, behavioral activation, habit formation, and cognitive flexibility, the paper argues that structured novelty promotes adaptive brain functioning, reduces rumination, and strengthens perceived self-efficacy. The intervention is simple, scalable, and consistent with evidence-based psychological models including cognitive behavioral therapy (CBT), behavioral activation, and neuroplasticity research.

Many individuals seeking improved mental health assume that change must be dramatic to be meaningful. In practice, the brain responds more reliably to small, repeated behavioral shifts than to large, unsustainable transformations. A simple framework — doing three new things every day for two weeks — illustrates how incremental novelty can support emotional stability and improved psychological functioning.

While the concept appears simplistic, it aligns closely with decades of research in neuroscience and clinical psychology. Novel experiences stimulate neuroplasticity, disrupt maladaptive cognitive loops, and foster a sense of agency that supports mental health recovery (Doidge, 2007; Garland et al., 2010).

Novelty and Neuroplasticity

The human brain is designed to adapt to new stimuli. Exposure to novel experiences promotes synaptic remodeling and strengthens neural pathways associated with learning and adaptability (Kolb & Gibb, 2011). Neuroplasticity research demonstrates that even minor environmental changes can alter neural firing patterns and support emotional flexibility.

Novelty also activates dopaminergic pathways involved in motivation and reward processing (Bunzeck & Düzel, 2006). This activation is particularly relevant for individuals experiencing depression or anxiety, as these conditions are often associated with reduced behavioral engagement and diminished reward sensitivity.

Engaging in three small new behaviors daily creates repeated neurological “interrupts” that reduce cognitive rigidity. Over time, this encourages a more flexible and resilient brain state.

Behavioral Activation and Mood Regulation

Behavioral activation, a core component of cognitive behavioral therapy, emphasizes structured engagement in meaningful activity to reduce depressive symptoms (Jacobson et al., 2001). The mechanism is straightforward: behavior often precedes emotional change rather than the reverse.

Doing three new things each day functions as a micro–behavioral activation protocol. These actions do not need to be dramatic. Examples might include:
• Taking a new walking route
• Trying a new food
• Starting a conversation with someone unfamiliar
• Listening to a new genre of music
• Writing a paragraph about an unfamiliar topic

Each new action interrupts avoidance patterns and reduces behavioral stagnation, which is a known contributor to mood disorders (Martell et al., 2010).

Cognitive Flexibility and Emotional Regulation

Mental health struggles frequently involve cognitive rigidity — repetitive thinking patterns, rumination, and black-and-white interpretations of experience. Introducing novelty promotes cognitive flexibility, the brain’s ability to shift perspectives and generate alternative interpretations (Kashdan & Rottenberg, 2010).

Cognitive flexibility is strongly associated with resilience and lower levels of anxiety and depression. When individuals intentionally introduce small new experiences, they train the brain to tolerate uncertainty and ambiguity. Over time, this reduces threat reactivity and promotes adaptive emotional responses.

This aligns with cognitive models suggesting that emotional distress is often maintained by rigid appraisal systems rather than external events themselves (Beck, 1976).

Self-Efficacy and Psychological Momentum

Another overlooked benefit of daily novelty is the development of self-efficacy — the belief in one’s ability to influence outcomes (Bandura, 1997). Mental health challenges frequently erode perceived control, leading to passivity and learned helplessness.

Completing three new actions daily provides repeated mastery experiences. These experiences accumulate quickly. Within two weeks, an individual completes 42 novel behaviors, creating measurable psychological momentum.

This momentum fosters a shift from passive coping to active engagement, reinforcing adaptive identity narratives such as:
“I am someone who can change things.”

Such shifts in self-perception are strongly associated with improved mental health outcomes (Bandura, 1997).

Interrupting Rumination and Emotional Looping

Rumination — repetitive, self-focused negative thinking — is a major risk factor for depression and anxiety (Nolen-Hoeksema et al., 2008). Novel behavior serves as a behavioral interruption that shifts attentional networks away from internal loops and toward external engagement.

Even small acts of novelty demand attentional resources, reducing the cognitive bandwidth available for rumination. Over repeated exposures, this can weaken entrenched rumination pathways and support more adaptive attentional patterns.

Why Two Weeks Matters

The two-week timeframe is psychologically significant. Research on habit formation suggests that while full habit consolidation takes longer, noticeable psychological shifts can occur within days of consistent behavioral change (Lally et al., 2010).

Two weeks is long enough to:
• Generate repeated neuroplastic stimulation
• Build behavioral momentum
• Produce early mastery experiences
• Shift attentional habits

Importantly, it is also short enough to feel achievable. Interventions that feel finite are more likely to be attempted and completed, increasing adherence.

Practical Implementation

The effectiveness of this strategy lies in its simplicity. The novelty requirement should remain intentionally modest. The goal is not intensity but consistency.

Guidelines include:
• The actions should be safe and manageable
• They should differ from routine behavior
• They do not need to be impressive
• Curiosity should be prioritized over performance

This low-pressure structure reduces avoidance and encourages experimentation, which is central to psychological growth.

Clinical Implications

From a therapeutic perspective, this framework can function as a bridge intervention. It is especially useful for:
• Individuals resistant to formal therapy
• Clients experiencing mild to moderate depression
• Early-stage behavioral activation
• Emotional intelligence training

It also aligns with strength-based approaches that emphasize agency and experiential learning rather than symptom focus (Seligman, 2011).

For clinicians, the exercise can be framed not as a cure but as a behavioral experiment — a stance consistent with CBT and REBT traditions that emphasize empirical self-testing (Ellis & Dryden, 1997).

Mental health improvement does not always require complex interventions. Small, structured novelty can create meaningful psychological shifts by engaging neuroplastic processes, disrupting rumination, and strengthening self-efficacy.

The practice of doing three new things daily for two weeks offers a simple yet evidence-aligned approach to mental health management. Its strength lies in accessibility: it requires no specialized tools, minimal planning, and little psychological preparation.

In a field often dominated by complexity, the power of small, consistent behavioral change remains one of the most reliable — and underutilized — tools for improving emotional well-being.

References

Bandura, A. (1997). Self-efficacy: The exercise of control. Freeman.

Beck, A. T. (1976). Cognitive therapy and the emotional disorders. International Universities Press.

Bunzeck, N., & Düzel, E. (2006). Absolute coding of stimulus novelty in the human substantia nigra/VTA. Neuron, 51(3), 369–379.

Doidge, N. (2007). The brain that changes itself. Viking.

Ellis, A., & Dryden, W. (1997). The practice of rational emotive behavior therapy. Springer.

Garland, E. L., et al. (2010). Upward spirals of positive emotions counter downward spirals of negativity. Clinical Psychology Review, 30(7), 849–864.

Jacobson, N. S., et al. (2001). Behavioral activation treatment for depression. Journal of Consulting and Clinical Psychology, 69(3), 255–264.

Kashdan, T. B., & Rottenberg, J. (2010). Psychological flexibility as a fundamental aspect of health. Clinical Psychology Review, 30(7), 865–878.

Kolb, B., & Gibb, R. (2011). Brain plasticity and behavior. Annual Review of Psychology, 62, 287–309.

Lally, P., et al. (2010). How habits are formed. European Journal of Social Psychology, 40(6), 998–1009.

Martell, C. R., Dimidjian, S., & Herman-Dunn, R. (2010). Behavioral activation for depression. Guilford Press.

Nolen-Hoeksema, S., et al. (2008). Rethinking rumination. Perspectives on Psychological Science, 3(5), 400–424.

Seligman, M. E. P. (2011). Flourish. Free Press.

02/25/2026

Working Memory, Short-Term Memory, and Long-Term Memory Across the Lifespan
Michael Cornwall, PsyD, PhD

Abstract

Human memory is not a single system but a constellation of interacting processes that support learning, identity, and adaptive functioning. Contemporary cognitive neuroscience distinguishes among working memory, short-term memory, and long-term memory as distinct but overlapping systems with different capacities, durations, and neural substrates. Across the lifespan, changes in memory performance are common and often misunderstood as global decline rather than selective shifts in processing speed, encoding efficiency, and executive control. This essay reviews the major memory systems, clarifies their functional differences, and explains why memory falters with advancing age. Emphasis is placed on differentiating normal cognitive aging from pathological processes and on understanding how attentional demands, neurobiological changes, and environmental factors contribute to subjective memory complaints. Understanding these distinctions has clinical relevance for psychoeducation, differential diagnosis, and realistic expectations about cognitive aging.

Introduction

Memory is often discussed as though it were a single faculty that weakens over time. In reality, memory is a dynamic system composed of multiple subsystems that serve different functions. Cognitive psychology and neuroscience have consistently identified three broad categories: working memory, short-term memory, and long-term memory (Baddeley, 2012; Cowan, 2010). Each system differs in duration, capacity, and neural architecture, and each is affected differently by aging.

Public discourse frequently equates aging with inevitable memory loss, but empirical evidence suggests a more nuanced reality. Some forms of memory decline modestly, particularly those tied to executive functioning and processing speed, while others remain stable or even improve with age (Salthouse, 2010). Clarifying these distinctions is essential for both clinical practice and public understanding, especially as subjective memory concerns increase in later adulthood.

Working Memory: The Mental Workspace

Working memory refers to the brain’s capacity to hold and manipulate information over short intervals in service of goal-directed behavior (Baddeley, 2012). Unlike passive storage systems, working memory is an active process that integrates attention, executive control, and temporary information buffering. It enables individuals to follow conversations, perform mental arithmetic, and maintain task goals in real time.

Neurobiologically, working memory is strongly associated with prefrontal cortical networks, particularly the dorsolateral prefrontal cortex (Miller & Cohen, 2001). Dopaminergic modulation plays a significant role in maintaining the stability of working memory representations, which partially explains why changes in dopamine signaling influence cognitive aging (Bäckman et al., 2006).

Capacity limits are a defining feature of working memory. Contemporary estimates suggest that individuals can maintain roughly four chunks of information at once, far fewer than older estimates of seven plus or minus two (Cowan, 2010). This limited capacity makes working memory especially vulnerable to distraction, stress, and fatigue. Clinically, many subjective memory complaints reflect working memory overload rather than true memory loss.

Short-Term Memory: Passive Holding

Short-term memory is closely related to working memory but conceptually distinct. It refers to the brief retention of information without active manipulation (Atkinson & Shiffrin, 1968). For example, recalling a phone number moments after hearing it involves short-term storage, whereas mentally reorganizing that number engages working memory.

Modern cognitive models often treat short-term memory as the storage component within the broader working memory system (Baddeley, 2012). While the distinction has blurred in contemporary literature, the conceptual separation remains clinically useful. Patients frequently report difficulty “remembering things for a minute,” which may reflect transient short-term storage inefficiencies rather than long-term memory impairment.

Short-term memory typically lasts seconds to a minute unless rehearsal or deeper encoding transfers the information into long-term storage. This encoding process depends heavily on attention, emotional salience, and contextual meaning (Craik & Lockhart, 1972).

Long-Term Memory: Durable Storage

Long-term memory encompasses relatively permanent storage systems that support knowledge, skills, and personal identity. It includes both declarative and non-declarative forms of memory (Squire & Dede, 2015). Declarative memory consists of episodic memories (personal experiences) and semantic memory (facts and knowledge), while non-declarative memory includes procedural learning, conditioning, and habits.

The hippocampus plays a central role in the encoding and consolidation of long-term memories, gradually distributing them across cortical networks for long-term storage (Squire & Wixted, 2011). Emotional experiences are often more vividly encoded due to amygdala involvement, which enhances consolidation through stress hormone modulation (McGaugh, 2004).

Importantly, long-term memory is not uniformly affected by aging. Semantic knowledge and crystallized intelligence often remain stable or improve across adulthood, reflecting accumulated experience and learning (Salthouse, 2010). This helps explain why older adults frequently retain deep knowledge despite reporting lapses in day-to-day recall.

Why Memory Changes With Age

Age-related changes in memory are multifactorial and rarely reflect a single cause. One of the most consistent findings is a decline in working memory efficiency. Reduced prefrontal cortex function, slower neural transmission, and changes in dopamine signaling contribute to reduced cognitive flexibility and attentional control (Bäckman et al., 2006; Park & Reuter-Lorenz, 2009).

Another major factor is reduced processing speed. Salthouse (1996) proposed that many cognitive declines can be traced to slower information processing, which affects encoding, retrieval, and multitasking. When the brain processes information more slowly, fewer details are encoded, leading to weaker memory traces.

Encoding inefficiency plays a central role in subjective memory complaints. Older adults often attribute forgetting to storage failure when the issue is actually incomplete encoding due to divided attention or environmental distraction (Craik & Rose, 2012). In other words, information that was never fully encoded cannot be retrieved later, creating the illusion of memory loss.

Neurobiological Contributors

Structural brain changes also contribute to memory differences across the lifespan. The hippocampus shows modest age-related volume reductions, which can affect new learning and spatial memory (Raz et al., 2005). However, such changes are typically gradual and remain within functional limits in healthy aging.

Neurotransmitter changes further influence cognitive efficiency. Age-related reductions in dopamine and acetylcholine affect attention, learning speed, and working memory maintenance (Bäckman et al., 2006). These neurochemical shifts do not eliminate memory but can reduce cognitive sharpness and flexibility.

Additionally, synaptic plasticity decreases with age, affecting the brain’s ability to form new neural connections. This contributes to slower learning rates but does not eliminate the capacity for neuroplastic change (Burke & Barnes, 2006).

Contextual and Lifestyle Factors

Beyond neurobiology, environmental and psychological factors significantly shape memory outcomes. Sleep disturbances, chronic stress, inflammation, and medical comorbidities disproportionately affect working memory and executive functioning (Lupien et al., 2009).

Retirement and reduced cognitive stimulation may also amplify perceived memory decline. Cognitive reserve theory suggests that lifelong mental engagement builds resilience against age-related changes, meaning that lifestyle factors can influence how memory aging manifests (Stern, 2012).

Importantly, emotional factors shape subjective memory perception. Anxiety and hypervigilance increase self-monitoring, making minor lapses more noticeable and distressing (Jonker et al., 2000). In clinical settings, reassurance and psychoeducation often reduce perceived impairment.

Normal Aging vs. Pathological Decline

Differentiating normal aging from pathological memory decline is clinically essential. Normal aging typically involves slower recall, mild word-finding pauses, and reduced multitasking capacity, while recognition memory remains relatively intact (Harada et al., 2013).

In contrast, neurodegenerative conditions involve progressive functional decline, impaired daily living skills, and significant disorientation. Alzheimer’s disease, for example, is marked by accelerated hippocampal atrophy and profound episodic memory impairment (Jack et al., 2010).

Understanding this distinction prevents over-pathologizing normal cognitive aging while supporting early identification of genuine neurocognitive disorders.

Preserved and Strengthened Abilities

While certain cognitive processes decline modestly, others remain stable or improve. Emotional regulation often improves with age, as older adults demonstrate greater resilience and perspective-taking (Carstensen et al., 2011). Semantic memory and pattern recognition frequently deepen, reflecting accumulated experience and heuristic learning.

These preserved domains contribute to what is often described as wisdom, characterized by integrative thinking and emotional balance. Such strengths highlight that cognitive aging involves redistribution rather than simple loss.

Conclusion

Memory is not a singular capacity that uniformly deteriorates with age but a complex system composed of interacting subsystems with distinct vulnerabilities and strengths. Working memory, which depends heavily on attention and executive control, is particularly sensitive to aging due to changes in prefrontal functioning, processing speed, and neurotransmitter dynamics. Short-term memory serves as a brief holding system closely tied to working memory processes, while long-term memory provides durable storage that often remains resilient, particularly in semantic domains.

Age-related memory changes are influenced by neurobiological, psychological, and environmental factors, making subjective memory complaints common but not necessarily pathological. Understanding these nuances is essential for clinicians, researchers, and the public alike. Rather than signaling inevitable decline, memory changes with age often reflect shifts in cognitive efficiency, attentional allocation, and neural modulation. Recognizing these patterns allows for more accurate assessment, realistic expectations, and a more balanced understanding of cognitive aging.

References

Atkinson, R. C., & Shiffrin, R. M. (1968). Human memory: A proposed system and its control processes. In K. W. Spence & J. T. Spence (Eds.), The psychology of learning and motivation (Vol. 2, pp. 89–195). Academic Press.

Baddeley, A. (2012). Working memory: Theories, models, and controversies. Annual Review of Psychology, 63, 1–29.

Bäckman, L., Nyberg, L., Lindenberger, U., Li, S. C., & Farde, L. (2006). The correlative triad among aging, dopamine, and cognition. Neuroscience & Biobehavioral Reviews, 30(6), 791–807.

Burke, S. N., & Barnes, C. A. (2006). Neural plasticity in the ageing brain. Nature Reviews Neuroscience, 7(1), 30–40.

Carstensen, L. L., Turan, B., Scheibe, S., et al. (2011). Emotional experience improves with age. Current Directions in Psychological Science, 20(1), 21–25.

Cowan, N. (2010). The magical mystery four: How is working memory capacity limited? Current Directions in Psychological Science, 19(1), 51–57.

Craik, F. I. M., & Lockhart, R. S. (1972). Levels of processing. Journal of Verbal Learning and Verbal Behavior, 11(6), 671–684.

Craik, F. I. M., & Rose, N. S. (2012). Memory encoding and aging. Wiley Interdisciplinary Reviews: Cognitive Science, 3(4), 409–422.

Harada, C. N., Natelson Love, M. C., & Triebel, K. (2013). Normal cognitive aging. Clinics in Geriatric Medicine, 29(4), 737–752.

Jack, C. R., Knopman, D. S., Jagust, W. J., et al. (2010). Hypothetical model of dynamic biomarkers of Alzheimer’s disease. The Lancet Neurology, 9(1), 119–128.

Jonker, C., Geerlings, M. I., & Schmand, B. (2000). Are memory complaints predictive for dementia? International Journal of Geriatric Psychiatry, 15(11), 983–991.

Lupien, S. J., McEwen, B. S., Gunnar, M. R., & Heim, C. (2009). Effects of stress throughout the lifespan. Nature Reviews Neuroscience, 10(6), 434–445.

McGaugh, J. L. (2004). The amygdala modulates memory consolidation. Annual Review of Neuroscience, 27, 1–28.

Miller, E. K., & Cohen, J. D. (2001). An integrative theory of prefrontal cortex function. Annual Review of Neuroscience, 24, 167–202.

Park, D. C., & Reuter-Lorenz, P. (2009). The adaptive brain. Annual Review of Psychology, 60, 173–196.

Raz, N., Lindenberger, U., Rodrigue, K. M., et al. (2005). Regional brain changes in aging. Cerebral Cortex, 15(11), 1676–1689.

Salthouse, T. A. (1996). The processing-speed theory of adult age differences. Psychological Review, 103(3), 403–428.

Salthouse, T. A. (2010). Major issues in cognitive aging. Oxford University Press.

Squire, L. R., & Dede, A. J. O. (2015). Conscious and unconscious memory systems. Cold Spring Harbor Perspectives in Biology, 7(3), a021667.

Squire, L. R., & Wixted, J. T. (2011). The cognitive neuroscience of human memory. Annual Review of Neuroscience, 34, 259–288.

Stern, Y. (2012). Cognitive reserve in ageing and Alzheimer’s disease. The Lancet Neurology, 11(11), 1006–1012.

02/23/2026

Agency in Psychological Change: Reframing the Role of Therapy and Medication

Michael Cornwall, PsyD, PhD
Cornwall Counseling Group, Las Vegas, Nevada, United States

Abstract

Contemporary discussions of mental health frequently rely on simplified language suggesting that psychotherapy and psychiatric medications “work” or “do not work.” While clinically convenient, this phrasing obscures the central mechanism of psychological change: patient agency. This article proposes a reframing in which therapy and medication are conceptualized as facilitators of skill acquisition rather than primary agents of change. Drawing from cognitive-behavioral and rational emotive traditions, along with psychopharmacology literature, the paper argues that durable improvement arises from patient engagement, repetition, and behavioral implementation. Medications are examined as physiological modifiers that may reduce barriers to learning but do not independently produce resilience. Special attention is given to benzodiazepines as a case example illustrating the risks of substituting relief for skill development. The article concludes by proposing a participation-based model of care that emphasizes internal capacity-building over intervention-centric language.

Agency in Psychological Change

The language used in mental health discourse shapes both expectations and outcomes. Common clinical shorthand suggests that therapy works or that medication works, implying a direct causal relationship between intervention and improvement. While useful for communication, this framing risks misattributing the locus of change. Psychological improvement does not occur because an intervention acts upon a passive recipient; it emerges from the patient’s active engagement in learning, practice, and behavioral adaptation.

Psychotherapy is best understood as a structured environment for skill acquisition. Across modalities, the consistent mechanism of change involves increased metacognitive awareness, emotional regulation, cognitive restructuring, and deliberate behavioral modification (Beck, 2011; Ellis & Dryden, 2007). These outcomes require rehearsal. Insight alone is insufficient. Without repeated application, therapeutic concepts remain abstract and exert minimal influence on lived experience. In this sense, psychotherapy resembles training rather than treatment in the traditional biomedical model.

This distinction becomes clearer when psychotherapy is examined through a behavioral lens. Adaptive emotional functioning develops through exposure, feedback, and repetition. Patients who improve typically demonstrate increased tolerance for discomfort, enhanced cognitive flexibility, and greater intentionality in behavior selection. None of these changes can be delivered externally. They must be enacted internally. The therapist’s contribution lies in structuring the learning process, not in producing the outcome directly.

Psychiatric medication occupies a related but distinct role. Pharmacological interventions can alter neurochemical conditions associated with mood, arousal, and attention, thereby influencing the ease with which individuals engage in adaptive behaviors (Stahl, 2021). Antidepressants may reduce affective intensity, stimulants may enhance attentional stability, and mood stabilizers may attenuate volatility. These physiological shifts can create conditions more conducive to learning and behavioral consistency. However, they do not independently confer coping skills, resilience, or psychological flexibility.

A useful conceptualization is that medication modifies the terrain rather than completing the journey. When neurobiological barriers decrease, individuals may find it easier to participate in therapy, sustain routines, or tolerate distress. Yet the fundamental mechanisms of change remain behavioral and cognitive. Without skill development, pharmacological benefits often plateau or diminish once environmental demands reassert themselves.

Benzodiazepines illustrate the importance of this distinction. These agents provide rapid anxiolytic effects through potentiation of inhibitory neurotransmission, often producing immediate subjective relief. However, tolerance and physiological dependence are well-documented outcomes of sustained use (Lader, 2011). As dosage ceilings are reached, clinical benefit may diminish while dependence risk increases. In such cases, symptom relief becomes decoupled from adaptive skill development, creating a vulnerability wherein individuals rely increasingly on pharmacological suppression rather than psychological capacity-building (Baldwin et al., 2014).

This pattern underscores a broader clinical principle: relief is not equivalent to resilience. Relief reduces immediate suffering, whereas resilience reflects an expanded capacity to function despite discomfort. The former may be externally mediated; the latter must be internally developed. When treatment models prioritize rapid symptom suppression without concurrent skill acquisition, they risk fostering dependency without fostering durability.

Reframing therapy and medication as facilitators rather than primary agents of change carries implications for clinical practice. It clarifies the role of the clinician as educator, collaborator, and capacity-builder rather than fixer. It also repositions the patient as an active participant whose engagement determines the trajectory of improvement. Such a perspective aligns with process-oriented models of psychotherapy, which emphasize participation, behavioral activation, and experiential learning as core drivers of outcome.

This participation-based model also provides a more coherent explanation for variability in treatment response. Differences in outcome are often attributed to modality, dosage, or provider skill. While these variables matter, patient engagement remains a powerful moderator. Individuals who actively practice skills, apply insights, and tolerate iterative discomfort tend to demonstrate more durable gains. Those who remain passive recipients often experience transient improvement that dissipates when external supports are removed.

Importantly, this reframing does not diminish the value of psychotherapy or pharmacotherapy. Rather, it situates them within a more accurate causal hierarchy. Interventions can catalyze change, lower barriers, and create opportunities for growth. They may provide leverage during periods of instability. But they do not substitute for the internal processes that produce lasting adaptation.

A participation-centered framework may also enhance clinical communication. When patients understand that therapy and medication support—but do not replace—their own efforts, expectations become more realistic. Treatment becomes a collaborative enterprise rather than a transactional one. This shift can foster greater accountability, reduce passivity, and promote sustained engagement.

Ultimately, psychological improvement is better understood as a function of agency than intervention alone. Therapy can guide, medication can stabilize, and clinicians can scaffold the process. Yet the enduring determinants of change remain practice, repetition, and willingness to engage discomfort in the service of growth. Interventions may open the door, but patients must still walk through it.

References

Baldwin, D. S., Aitchison, K., Bateson, A., Curran, H. V., Davies, S., Leonard, B., Nutt, D. J., Stephens, D. N., & Wilson, S. (2014). Benzodiazepines: Risks and benefits. Journal of Psychopharmacology, 28(11), 967–971.

Beck, J. S. (2011). Cognitive behavior therapy: Basics and beyond (2nd ed.). Guilford Press.

Ellis, A., & Dryden, W. (2007). The practice of rational emotive behavior therapy (2nd ed.). Springer.

Lader, M. (2011). Benzodiazepines revisited—Will we ever learn? Addiction, 106(12), 2086–2109.

Stahl, S. M. (2021). Stahl’s essential psychopharmacology (5th ed.). Cambridge University Press.

Address

2785 E Desert Inn Road, Suite 280
Las Vegas, NV
89121

Opening Hours

Monday	10am - 5:30pm
Tuesday	10am - 5:30pm
Wednesday	10am - 5:30pm
Thursday	10am - 5:30pm
Saturday	10am - 5:30pm

Telephone

+18593214956

Website

https://cornwallcounseling.com/

Alerts

Be the first to know and let us send you an email when Dr. Michael Cørnwall posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Dr. Michael Cørnwall